Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Atrial Fibrillatiion
Decision to use anticoagulant therapy must take gender into consideration
November 18th, 2005
Decision to use anticoagulant therapy must take gender into consideration, since female sex is an independent risk factor for thromboembolism. "Previous studies provide conflicting results about whether women are at higher risk than men for thromboembolism in the setting of atrial fibrillation (AF)," remarked scientists from the United States. "They examined data from a large contemporary cohort of AF patients to address this question." M. C. Fang and colleagues, University California at San Francisco, "prospectively studied 13,559 adults with AF and recorded data on patients' clinical characteristics and the occurrence of incident hospitalizations...
Source: Drug Week (2005-11-18)
|
